Works matching AU Minnema, Monique

Results: 78
    1
    2
    3
    4
    5

    Women in Lymphoma: A 4‐year journey in promoting gender equity.

    Published in:
    Hematological Oncology, 2024, v. 42, n. 6, p. 1, doi. 10.1002/hon.3183
    By:
    • Trotman, Judith;
    • LaCasce, Ann;
    • Osborne, Wendy;
    • Steiner, Anna;
    • Hawkes, Eliza;
    • Casulo, Carla;
    • Broussais, Florence;
    • Cwynarksi, Kate;
    • Ghione, Paola;
    • Kahn, Justine;
    • Kurtz, Sharyn;
    • Linton, Kim;
    • Mahuad, Carolina;
    • Minnema, Monique;
    • Nastoupil, Loretta;
    • Pavlovsky, Astrid;
    • Poon, Michelle;
    • Sarkozy, Clémentine;
    • Sehn, Laurie;
    • Smith, Soni
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13

    Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma.

    Published in:
    British Journal of Haematology, 2021, v. 195, n. 3, p. 388, doi. 10.1111/bjh.17673
    By:
    • Topp, Max S.;
    • van Meerten, Tom;
    • Houot, Roch;
    • Minnema, Monique C.;
    • Bouabdallah, Krimo;
    • Lugtenburg, Pieternella J.;
    • Thieblemont, Catherine;
    • Wermke, Martin;
    • Song, Kevin W.;
    • Avivi, Irit;
    • Kuruvilla, John;
    • Dührsen, Ulrich;
    • Zheng, Yan;
    • Vardhanabhuti, Saran;
    • Dong, Jinghui;
    • Bot, Adrian;
    • Rossi, John M.;
    • Plaks, Vicki;
    • Sherman, Marika;
    • Kim, Jenny J.
    Publication type:
    Article
    14

    Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma.

    Published in:
    British Journal of Haematology, 2021, v. 194, n. 4, p. 690, doi. 10.1111/bjh.17527
    By:
    • Oluwole, Olalekan O.;
    • Bouabdallah, Krimo;
    • Muñoz, Javier;
    • De Guibert, Sophie;
    • Vose, Julie M.;
    • Bartlett, Nancy L.;
    • Lin, Yi;
    • Deol, Abhinav;
    • McSweeney, Peter A.;
    • Goy, Andre H.;
    • Kersten, Marie José;
    • Jacobson, Caron A.;
    • Farooq, Umar;
    • Minnema, Monique C.;
    • Thieblemont, Catherine;
    • Timmerman, John M.;
    • Stiff, Patrick;
    • Avivi, Irit;
    • Tzachanis, Dimitrios;
    • Kim, Jenny J.
    Publication type:
    Article
    15

    HOVON 104, long‐term follow‐up of bortezomib‐dexamethasone induction therapy followed by autologous stem cell transplantation in newly diagnosed AL amyloidosis patients.

    Published in:
    EJHaem, 2024, v. 5, n. 4, p. 815, doi. 10.1002/jha2.918
    By:
    • Minnema, Monique C.;
    • Nasserinejad, Kazem;
    • Hegenbart, Ute;
    • Ypma, Paula F.;
    • Wu, Ka Lung;
    • Kersten, Marie Jose;
    • Croockewit, Sandra;
    • Zweegman, Sonja;
    • Tick, Lidwine;
    • Broijl, Annemiek;
    • Koene, Harry;
    • Bos, Gerard M. J.;
    • Sonneveld, Pieter;
    • Schönland, Stefan O.
    Publication type:
    Article
    16
    17
    18

    P-212: DREAMM-5 platform trial: Belantamab mafodotin (belamaf; GSK2857916) in combination with five different novel agents in patients with relapsed/refractory multiple myeloma (RRMM).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S156, doi. 10.1016/S2152-2650(21)02339-9
    By:
    • Richardson, Paul G.;
    • Trudel, Suzanne;
    • Callander, Natalie S.;
    • Nooka, Ajay;
    • Song, Kevin;
    • Uttervall, Katarina;
    • Minnema, Monique C.;
    • Rodríguez-Otero, Paula;
    • Struemper, Herbert;
    • Yeakey, Anne;
    • de Oca, Rocio Montes;
    • Smith, L. Mary;
    • Jackson, Nicola;
    • Kaisermann, Morrys;
    • Im, Ellie;
    • Basile, Frank G.;
    • Ahlers, Christoph M.;
    • Holkova, Beata;
    • Gupta, Ira;
    • Kremer, Brandon E.
    Publication type:
    Article
    19
    20

    OAB-025: Talquetamab, a G protein-coupled receptor family C group 5 member D (GPRC5D)×CD3 bispecific antibody, in relapsed/refractory multiple myeloma (RRMM): Updated results of a phase 1, first-in-human study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S16, doi. 10.1016/S2152-2650(21)02099-1
    By:
    • Donk, Niels W.C.J. van de;
    • Krishnan, Amrita;
    • Oriol, A;
    • Berdeja, Jesus G.;
    • Rodríguez-Otero, Paula;
    • Askari, Elham;
    • Mateos, María-Victoria;
    • Minnema, Monique C.;
    • Costa, Luciano;
    • Verona, Raluca;
    • Girgis, Suzette;
    • Prior, Thomas;
    • Hilder, Brandi;
    • Russell, Jeffery;
    • Goldberg, Jenna;
    • Chari, Ajai
    Publication type:
    Article
    21

    A Noninterventional, Observational, European Post-Authorization Safety Study of Patients With Relapsed/Refractory Multiple Myeloma Treated With Lenalidomide.

    Published in:
    2020
    By:
    • Gamberi, Barbara;
    • Berthou, Christian;
    • Hernandez, Miguel;
    • Semenzato, Gianpietro;
    • Tholouli, Eleni;
    • Hájek, Roman;
    • Caers, Jo;
    • Dimopoulos, Meletios;
    • Minnema, Monique C.;
    • Andreasson, Bjorn;
    • Parreira, Joana;
    • Crotty, Gerard;
    • Remes, Kari;
    • Kueenburg, Elisabeth;
    • Rosettani, Barbara;
    • Di Micco, Antonia;
    • Peters, Sarah;
    • Bacon, Pamela;
    • Blau, Igor Wolfgang
    Publication type:
    journal article
    22
    23
    24
    25
    26
    27
    28

    Daratumumab Plus Bortezomib, Thalidomide, and Dexamethasone (D-VTd) in Transplant-eligible Newly Diagnosed Multiple Myeloma (NDMM): Subgroup Analysis of High-risk Patients (Pts) in CASSIOPEIA.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e2, doi. 10.1016/j.clml.2019.09.004
    By:
    • Sonneveld, Pieter;
    • Attal, Michel;
    • Perrot, Aurore;
    • Hulin, Cyrille;
    • Caillot, Denis;
    • Facon, Thierry;
    • Leleu, Xavier;
    • Belhadj-Merzoug, Karim;
    • Karlin, Lionel;
    • Benboubker, Lofti;
    • Levin, Mark-David;
    • Minnema, Monique;
    • Westerman, Matthijs;
    • Delforge, Michel;
    • Zweegman, Sonja;
    • Pei, Lixia;
    • de Boer, Carla;
    • Vanquickelberghe, Véronique;
    • Kampfenkel, Tobias;
    • Moreau, Philippe
    Publication type:
    Article
    29
    30

    Acalabrutinib in Patients (pts) with Waldenström Macroglobulinemia (WM).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S285, doi. 10.1016/j.clml.2018.07.222
    By:
    • Owen, Roger;
    • McCarthy, Helen;
    • Rule, Simon;
    • D'Sa, Shirley;
    • Thomas, Sheeba;
    • Forconi, Francesco;
    • Anderson, Thomas;
    • Kersten, Marie José;
    • Zinzani, Pier Luigi;
    • Iyengar, Sunil;
    • Kothari, Jaimal;
    • Minnema, Monique;
    • Kastritis, Efstathios;
    • Izumi, Raquel;
    • Slatter, J. Greg;
    • Mittag, Diana;
    • Wei, Helen;
    • Chen, Dih-Yin;
    • Patel, Priti;
    • Furman, Richard R.
    Publication type:
    Article
    31

    Allogeneic Hematopoietic Cell Transplantation Outcomes After Nivolumab Monotherapy for Relapsed/Refractory Hodgkin Lymphoma (CA209-039 and CheckMate 205).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S326, doi. 10.1016/j.clml.2017.07.136
    By:
    • Carlo-Stella, Carmelo;
    • Collins, Graham P.;
    • Armand, Philippe;
    • Zinzani, Pier Luigi;
    • Cohen, Jonathon B.;
    • Halwani, Ahmad;
    • Millenson, Michael;
    • Provencio, Mariano;
    • Domenech, Eva Domingo;
    • Giulino-Roth, Lisa;
    • Castagna, Luca;
    • Kato, Kazunobu;
    • McKiver, Mihaela Popa;
    • Sumbul, Anne;
    • Zhu, Lili;
    • Trneny, Marek;
    • Minnema, Monique C.;
    • Rueda, Antonio;
    • Cunningham, David;
    • Reddy, Nishitha
    Publication type:
    Article
    32

    European Post-Approval Safety Study (EU Pass) of Relapsed/Refractory Multiple Myeloma (RRMM): Safety, Including Second Primary Malignancies, in a Large Cohort of Patients (Pts) Treated With Lenalidomide (LEN), Thalidomide (THAL), and Bortezomib (BORT).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e65, doi. 10.1016/j.clml.2017.03.118
    By:
    • Gamberi, Barbara;
    • Hernandez, Miguel T.;
    • Berthou, Christian;
    • Tholouli, Eleni;
    • Zamagni, Elena;
    • Hajek, Roman;
    • Minnema, Monique;
    • Dimopoulos, Meletios Athanasios;
    • Caers, Jo;
    • Andersen, Niels Frost;
    • Andreasson, Bjorn;
    • Waage, Anders;
    • Crotty, Gerard;
    • Kueenburg, Elisabeth;
    • Rosettani, Barbara;
    • Di Micco, Antonio;
    • Bacon, Pamela;
    • Blau, Igor Wolfgang
    Publication type:
    Article
    33

    Analysis of Efficacy and Prognostic Factors of Lenalidomide Treatment as Part of a Dutch Compassionate Use Program.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 2, p. 138, doi. 10.3816/CLML.2010.n.020
    By:
    • Kneppers, Evelien;
    • Lokhorst, Henk M.;
    • Eeltink, Corien M.;
    • Huls, Gerwin;
    • Kersten, Marie José;
    • Koedam, Jan;
    • Minnema, Monique C.;
    • van Oers, Marinus H. J.;
    • Raymakers, Reinier A. P.;
    • Schaafsma, Martijn R.;
    • Vellenga, Edo;
    • Wijermans, Pierre W.;
    • Wittebol, Shulamiet;
    • Sonneveld, Pieter;
    • Zweegman, Sonja
    Publication type:
    Article
    34
    35

    Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study.

    Published in:
    Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01379-0
    By:
    • Shah, Bijal D.;
    • Ghobadi, Armin;
    • Oluwole, Olalekan O.;
    • Logan, Aaron C.;
    • Boissel, Nicolas;
    • Cassaday, Ryan D.;
    • Leguay, Thibaut;
    • Bishop, Michael R.;
    • Topp, Max S.;
    • Tzachanis, Dimitrios;
    • O'Dwyer, Kristen M.;
    • Arellano, Martha L.;
    • Lin, Yi;
    • Baer, Maria R.;
    • Schiller, Gary J.;
    • Park, Jae H.;
    • Subklewe, Marion;
    • Abedi, Mehrdad;
    • Minnema, Monique C.;
    • Wierda, William G.
    Publication type:
    Article
    36

    Randomized controlled trial on the effects of a supervised high intensity exercise program in patients with a hematologic malignancy treated with autologous stem cell transplantation: Results from the EXIST study.

    Published in:
    PLoS ONE, 2017, v. 12, n. 7, p. 1, doi. 10.1371/journal.pone.0181313
    By:
    • Persoon, Saskia;
    • ChinAPaw, Mai J. M.;
    • Buffart, Laurien M.;
    • Liu, Roberto D. K.;
    • Wijermans, Pierre;
    • Koene, Harry R.;
    • Minnema, Monique C.;
    • Lugtenburg, Pieternella J.;
    • Marijt, Erik W. A.;
    • Brug, Johannes;
    • Nollet, Frans;
    • Kersten, Marie José
    Publication type:
    Article
    37
    38

    The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands.

    Published in:
    Cancers, 2023, v. 15, n. 17, p. 4334, doi. 10.3390/cancers15174334
    By:
    • Spanjaart, Anne M.;
    • Pennings, Elise R. A.;
    • Mutsaers, Pim G. N. J.;
    • van Dorp, Suzanne;
    • Jak, Margot;
    • van Doesum, Jaap A.;
    • de Boer, Janneke W.;
    • Niezink, Anne G. H.;
    • Kos, Milan;
    • Vermaat, Joost S. P.;
    • Sijs-Szabo, Aniko;
    • van der Poel, Marjolein W. M.;
    • Nijhof, Inger S.;
    • Kuipers, Maria T.;
    • Chamuleau, Martine E. D.;
    • Lugtenburg, Pieternella J.;
    • Doorduijn, Jeanette K.;
    • Serroukh, Yasmina I. M.;
    • Minnema, Monique C.;
    • van Meerten, Tom
    Publication type:
    Article
    39
    40
    41
    42

    The Changing Landscape of Smoldering Multiple Myeloma: A European Perspective.

    Published in:
    Oncologist, 2016, v. 21, n. 3, p. 333, doi. 10.1634/theoncologist.2015-0303
    By:
    • Caers, Jo;
    • Fernández de Larrea, Carlos;
    • Leleu, Xavier;
    • Heusschen, Roy;
    • Zojer, Niklas;
    • Decaux, Olivier;
    • Kastritis, Efstathios;
    • Minnema, Monique;
    • Jurczyszyn, Artur;
    • Beguin, Yves;
    • Wäsch, Ralph;
    • Palumbo, Antonio;
    • Dimopoulos, Meletios;
    • Mateos, Maria Victoria;
    • Ludwig, Heinz;
    • Engelhardt, Monika
    Publication type:
    Article
    43
    44
    45

    Bortezomib maintenance after R‐CHOP, cytarabine and autologous stem cell transplantation in newly diagnosed patients with mantle cell lymphoma, results of a randomised phase II HOVON trial.

    Published in:
    British Journal of Haematology, 2020, v. 190, n. 3, p. 385, doi. 10.1111/bjh.16567
    By:
    • Doorduijn, Jeanette K.;
    • Zijlstra, Josee M.;
    • Lugtenburg, Pieternella J.;
    • Kersten, Marie Josee;
    • Böhmer, Lara H.;
    • Minnema, Monique C.;
    • MacKenzie, Marius A.;
    • van Marwijk Kooij, Rien;
    • Jongh, Eva;
    • Snijders, Tjeerd J.F.;
    • Weerdt, Okke;
    • Gelder, Michel;
    • Hoogendoorn, Mels;
    • Leys, Rineke B.L.;
    • Kibbelaar, Robby E.;
    • Jong, Daphne;
    • Chitu, Dana A.;
    • Van't Veer, Mars B.;
    • Kluin‐Nelemans, Hanneke C.
    Publication type:
    Article
    46

    Enduring efficacy and tolerability of daratumumab in combination with lenalidomide and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma (GEN503): final results of an open‐label, phase 1/2 study.

    Published in:
    British Journal of Haematology, 2019, v. 186, n. 3, p. e35, doi. 10.1111/bjh.15879
    By:
    • Plesner, Torben;
    • Arkenau, Hendrik‐Tobias;
    • Gay, Francesca;
    • Minnema, Monique C.;
    • Boccadoro, Mario;
    • Moreau, Philippe;
    • Cavenagh, Jamie;
    • Perrot, Aurore;
    • Laubach, Jacob P.;
    • Krejcik, Jakub;
    • Ahmadi, Tahamtan;
    • Boer, Carla;
    • Chen, Diana;
    • Chiu, Christopher;
    • Schecter, Jordan M.;
    • Richardson, Paul G.
    Publication type:
    Article
    47
    48
    49
    50